Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
- PMID: 31501170
- PMCID: PMC6768774
- DOI: 10.9778/cmajo.20190040
Prevalence of chronic kidney disease and cardiovascular comorbidities in adults in First Nations communities in northwest Ontario: a retrospective observational study
Abstract
Background: The prevalence of adult chronic kidney disease and cardiovascular comorbidities in Canadian Indigenous communities is largely unknown. We conducted a study to document the prevalence of chronic kidney disease and concurrent diabetes mellitus, hypertension and dyslipidemia in a First Nations population in northwest Ontario.
Methods: In this observational study, we used retrospective data collected from regional electronic medical records of 16 170 adults (age ≥ 18 yr) from 26 First Nations communities in northwest Ontario from May 2014 to May 2017. Demographic and laboratory data included age, gender, prescribed medications, estimated glomerular filtration rate, urine albumin:creatinine ratio, low-density lipoprotein cholesterol (LDL-C) level and glycated hemoglobin (HbA1c) concentration. We identified patients with diabetes by an HbA1c concentration of 6.5% or higher, or the use of a diabetic medication, those with dyslipidemia by an elevated LDL-C level (≥ 2.0 mmol/L) or use of lipid-lowering medication, and those with hypertension by use of antihypertensive medication.
Results: Of the 16 170 adults residing in the communities, 5224 unique patients (32.3%) had renal testing (albumin:creatinine ratio and/or estimated glomerular filtration rate). The age-adjusted prevalence of chronic kidney disease was 14.5%, and the prevalence of stage 3-5 chronic kidney disease (estimated glomerular filtration rate < 60 mL/min) was 7.0%. Most patients with chronic kidney disease (1487 [80.0%]) had at least 1 cardiovascular comorbidity. A total of 1332 patients (71.6%) had diabetes, 1313 (70.6%) had dyslipidemia, and 1098 (59.1%) had hypertension; all 3 comorbidities were present in 716 patients (38.5%).
Interpretation: We document a high prevalence of advanced chronic kidney disease in this First Nations population, 7.0%, double the rate in the general population. High rates of cardiovascular comorbidities were also common in these patients with chronic kidney disease, which places them at increased risk for cardiovascular disease.
Copyright 2019, Joule Inc. or its licensors.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Diabetes prevalence and demographics in 25 First Nations communities in northwest Ontario (2014-2017).Can J Rural Med. 2020 Oct-Dec;25(4):139-144. doi: 10.4103/CJRM.CJRM_99_19. Can J Rural Med. 2020. PMID: 33004699
-
The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program.Am J Kidney Dis. 2016 Oct;68(4):582-590. doi: 10.1053/j.ajkd.2016.04.014. Epub 2016 May 30. Am J Kidney Dis. 2016. PMID: 27257016
-
Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.Swiss Med Wkly. 2017 Jul 6;147:w14459. doi: 10.4414/smw.2017.14459. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28695552
-
Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study.Acta Diabetol. 2021 Dec;58(12):1615-1625. doi: 10.1007/s00592-021-01765-z. Epub 2021 Jun 28. Acta Diabetol. 2021. PMID: 34181081
-
Mobile Diabetes Telemedicine Clinics for Aboriginal First Nation People With Reported Diabetes in British Columbia.Can J Diabetes. 2021 Feb;45(1):89-95. doi: 10.1016/j.jcjd.2020.05.018. Epub 2020 Jun 7. Can J Diabetes. 2021. PMID: 33011131 Review.
Cited by
-
The impact of community-based non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote dwelling Indigenous communities: A scoping review protocol.PLoS One. 2022 Jun 10;17(6):e0269839. doi: 10.1371/journal.pone.0269839. eCollection 2022. PLoS One. 2022. PMID: 35687551 Free PMC article.
-
Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.PLoS One. 2022 Apr 14;17(4):e0267051. doi: 10.1371/journal.pone.0267051. eCollection 2022. PLoS One. 2022. PMID: 35421173 Free PMC article.
-
Exploring diabetes status and social determinants of health influencing diabetes-related complications in a Northwestern community, Ontario, Canada: A mixed method study protocol.PLoS One. 2023 Sep 28;18(9):e0273953. doi: 10.1371/journal.pone.0273953. eCollection 2023. PLoS One. 2023. PMID: 37768913 Free PMC article.
-
Saskatoon Berry Amelanchier alnifolia Regulates Glucose Metabolism and Improves Cardiovascular and Liver Signs of Diet-Induced Metabolic Syndrome in Rats.Nutrients. 2020 Mar 27;12(4):931. doi: 10.3390/nu12040931. Nutrients. 2020. PMID: 32230955 Free PMC article.
-
Impact of point-of-care screening for hypertension, diabetes and progression of chronic kidney disease in rural Manitoba Indigenous communities.CMAJ. 2021 Jul 19;193(28):E1076-E1084. doi: 10.1503/cmaj.201731. CMAJ. 2021. PMID: 34281964 Free PMC article.
References
-
- Zelmer JL. The economic burden of end-stage renal disease in Canada. Kidney Int. 2007;72:1122–9. - PubMed
-
- Komenda P, Lavallee B, Ferguson TW, et al. The prevalence of CKD in rural Canadian Indigenous peoples: results from the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) screen, triage, and treat program. Am J Kidney Dis. 2016;68:582–90. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous